Home
About Us
Company Profile
Company Milestone
Qualification Honor
Recruitment
Products
Comprehensive Spinal Solutions
Joint Solutions
Limbs and Sports Medicine
Oral And Craniofacial Solutions
Vascular Interventional Solutions
3D Printing Model Guide
News
Company News
Contact
News quick view: Premier Li Qiang of the State Council presided over an executive meeting of the State Council on August 25 to examine and approve the Action Plan for the High-quality Development of the Pharmaceutical Industry (2023-2025).
Xinhua News Agency, Beijing, August 25-Premier Li Qiang of the State Council presided over an executive meeting of the State Council on August 25 to examine and approve the Action Plan for High-quality Development of the Pharmaceutical Industry (2023-2025), the Action Plan for High-quality Development of the Medical equipment Industry (202025) and the guidance on Planning and Construction of indemnificatory Housing. The meeting stressed that the pharmaceutical industry and medical equipment industry are an important foundation of health care, which is related to the overall situation of people's life and health and high-quality development. Efforts should be made to improve the resilience and modernization level of the pharmaceutical industry and medical equipment industry, enhance the supply capacity of high-end drugs, key technologies and raw materials, and accelerate the completion of China's high-end medical equipment short board.
29
2024
/
03
Hua Xiang Helps Training in Clinical Innovation and Application of New Medical Technologies-Changsha Station Successfully Held
On March 24, sponsored by China Medical Electronic Audio and Video Publishing House Co., Ltd., the "National Tour of Clinical Innovation and Application Training of New Medical Technologies and Musculoskeletal Pain Visualization Regeneration Technology Training Course" was held in Changsha, Hunan.
27
2023
In January, porous tantalum interbody fusion device and collar internal fixation system were approved by NMPA<Br /> In December, successfully organized and led the "14th Five-Year Plan" national key science and technology research and development project.
08
2022
In March, the porous interbody fusion cage was approved by NMPA for listing;<br />In April, the anterior cervical nail plate fixation system was approved by the NMPA for listing;<br />In December, the skull plate fixation system was approved by the NMPA for listing;<br />In December, the posterior thoracolumbar nail rod fixation system was approved by the NMPA for listing.
2021
In February, the porous vertebral body fusion device was approved by NMPA for listing;<br />In October, the degradable zinc alloy maxillofacial internal fixation system was started clinically.
2020
In August, personalized surgical planning aids and customized surgical guides were approved;<br />In October, clinical surgery for biodegradable zinc alloy internal fixation products was carried out.
2019
In September, it was recognized as a high-tech enterprise;<br />In October, laser 3D printing personalized porous tantalum implant was awarded by the Ministry of Industry and Information Technology. the results identified;<br />In December, Hunan Huarui Technology Group Co., Ltd. was established and completed the equity reorganization of the branch, and officially entered the group management.
2018
In July, passed the International Organization for Standardization ISO9001:2015 audit certification;<br />In December, he won the Global Innovation Award for Additive Manufacturing.